Mustang Bio, Inc.
MBIONASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $2.60M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.37$1.69
- Volume (live)
- -
- Avg. volume (3M)
- 38.38K
Mustang Bio (MBIO) Stock Price & Financial Analysis
Mustang Bio Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.37 - $0.39 |
|---|---|
| 52-Week High | $1.69 |
| 52-Week Low | $0.37 |
| Open | $0.37 |
| Volume (last close) | 31.56K |
| Average Volume (3M) | 38.38K |
| 50-Day MA | $0.52 |
|---|---|
| 200-Day MA | $0.73 |
| 1-Year Change | −74.60% |
| Market Cap | 2.60M |
|---|---|
| Shares Outstanding | 6.73M |
| Price to Book (P/B) | 0.34 |
| EV/EBITDA | 3.94 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Mustang Bio at a Glance
As of the Oct 15, 2026 close, Mustang Bio (MBIO) has a market capitalization of $2.60M.
As of its latest reported balance sheet, it holds $15.15M in cash and securities against $0.00 of debt, a net cash position of $15.15M.
Mustang Bio does not currently pay a dividend.
The share price is down 74.6% over the past year. At $0.39 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $0.37 to $1.69, below its 200-day moving average of $0.73.
Frequently Asked Questions About Mustang Bio
What is the current stock price for MBIO?
As of the Oct 15, 2026 close, MBIO stock trades at $0.39. The 52-week range is $0.37–$1.69, with a day range of $0.37–$0.39.
What is the P/E ratio for MBIO?
The P/E ratio (Price-to-Earnings) for MBIO is shown in the Key Statistics section. This valuation metric helps compare Mustang Bio, Inc. to industry peers.
Does MBIO pay dividends?
Mustang Bio does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MBIO?
Analyst ratings and recommendations for MBIO are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MBIO?
As of the Oct 15, 2026 close, Mustang Bio's market capitalization is $2.6M, classifying it as a micro-cap company. Mustang Bio operates in the Healthcare sector within the Biotechnology industry.